A

Alivus Life Sciences Ltd

Pharmaceuticals

SMALLCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 6 analysts offering recommendations for Alivus Life Sciences Ltd

83%

Buy

17%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio25.6051.49
PB Ratio5.176.67
Dividend Yield2.29%0.52%

Understand what these metrics mean. 

About the company

A

Alivus Life Sciences Ltd

Glenmark Life Sciences Ltd is a manufacturer of pharmaceutical preparation. The Company was founded in June 2011 and is located in Solapur, India.

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions